The legal standard for inventorship is complex and can be particularly difficult in the context of university research.
While filing a patent involving sole inventorship is a breeze, it’s rarely the case in the university setting. Joint inventorship is more common, and it is necessary to evaluate whether the contribution of each individual in the lab — including students and post-docs — constitutes inventive activity according to the Patent Act. Even more complexity arises when researchers and labs from more than one institution are involved, or when a scientist with a corporate partner has contributed to the innovation. Things can start to get sticky, egos get bruised, and relationships with key inventors and partners can get damaged. Additionally, incorrectly determining inventorship can lead to patenting and commercialization delays and huge, costly legal headaches.
But, there are strict guidelines set forth in the Patent Act to determine inventorship. This important webinar will help you and your staff fully understand the parameters of each type of inventorship and avoid the damaging consequences of inventorship disputes.
Technology Transfer Tactics’ Distance Learning Division has secured a highly respected patent attorney to lead this important program:
Determining Inventorship for University IP
Join Sherry L. Murphy from the law firm Myers Bigel for this critical and detailed webinar that will discuss:
- Why Inventorship is important
- Legal requirements
- Potential consequences of errors
- Overview of Inventorship legal standards
- Changes regarding Inventorship under the America Invents Act
- Inventorship evaluation tips
- Questions to ask contributors
- When to obtain more in-depth legal advice
- Special considerations involving:
- Inter-Institution collaboration
- Industry Sponsorship
PLUS: Here the original recording from the live Q&A!
Meet Your Program Leader:
Sherry L. Murphy
Shareholder – Myers Bigel, PA
Sherry is a member of the firm’s biotechnology and chemical patent practice group, counseling clients on the procurement of patent protection in the U.S. and internationally, and assisting in freedom to operate and due diligence review for their innovations. She has extensive experience with a variety of inventions, including small molecule pharmaceuticals, personalized medicine, drug delivery systems, tissue engineering and medical devices.
Sherry is a member of the North Carolina bar and is registered to practice before the U.S. Patent and Trademark Office. She is an active member of the AIPLA biotechnology group and is past president of the Carolina Patent Trademark and Copyright Law Association (CPTCLA).